Company / Current Assets
TG Therapeutics, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$630.8M
FY2025
5-year range
$168.3M / $630.8M
FY2021-FY2025
Trend
+11.4%
vs FY2024
Sector context
#95 of 213
Health Care
What the data says
At $631M, TG Therapeutics, Inc.'s current assets ranks #95 of 213 in the Health Care sector. Current Assets has increased for 3 consecutive years, from $168M in FY2022 to $631M in FY2025.
Based on SEC 10-K filings.
$631M in FY2025 with a 5-year CAGR of +0.6%.
Improved from $318M to $631M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +55.3%
- 5-Year CAGR
- +0.6%
- 10-Year CAGR
- -
Sector benchmark
#95 of 213 in Health CareTop 45% of 213This company $630.8M Sector average $2.5B
▼
-75.0% below sector average
Key checks
Key Insights
- TG Therapeutics, Inc.'s current assets has grown for 3 consecutive years.
- 5-year CAGR of +0.6%, indicating consistent growth.
- In FY2025, current assets increased 11.4% year-over-year.
- Ranks #95 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $630.8M | +11.4% |
| FY2024 | $566.4M | +78.1% |
| FY2023 | $317.9M | +88.9% |
| FY2022 | $168.3M | -49.2% |
| FY2021 | $331.0M | -45.9% |
| FY2020 | $611.7M | +310.1% |
| FY2019 | $149.2M | +88.7% |
| FY2018 | $79.0M | -15.3% |
| FY2017 | $93.3M | +83.5% |
| FY2016 | $50.9M | -41.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026